Sphingosine kinase inhibitors and cancer: seeking the golden sword of Hercules.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Cancer Research

• Publication date

  2011-11-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1158/0008-5472.CAN-11-2364PMID 21940750PMCID PMC3206172
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Exploring anti-TGF-β therapies in cancer and fibrosis

  2011cited by this paper
• Development of amidine-based sphingosine kinase 1 nanomolar inhibitors and reduction of sphingosine 1-phosphate in human leukemia cells.

  2011cited by this paper
• FTY720 Analogues as Sphingosine Kinase 1 Inhibitors

  2011influential reference
• Pharmacological inhibition of sphingosine kinase isoforms alters estrogen receptor signaling in human breast cancer.

  2011cited by this paper
• Sphingosine‐1‐phosphate produced by sphingosine kinase 2 in mitochondria interacts with prohibitin 2 to regulate complex IV assembly and respiration

  2011cited by this paper
• (R)-FTY720 methyl ether is a specific sphingosine kinase 2 inhibitor: Effect on sphingosine kinase 2 expression in HEK 293 cells and actin rearrangement and survival of MCF-7 breast cancer cells.

  2011cited by this paper
• FTY720 and (S)-FTY720 vinylphosphonate inhibit sphingosine kinase 1 and promote its proteasomal degradation in human pulmonary artery smooth muscle, breast cancer and androgen-independent prostate cancer cells

  2010influential reference
• High expression of sphingosine 1-phosphate receptors, S1P1 and S1P3, sphingosine kinase 1, and extracellular signal-regulated kinase-1/2 is associated with development of tamoxifen resistance in estrogen receptor-positive breast cancer patients.

  2010cited by this paper
• SPHINGOSINE-1-PHOSPHATE: A MISSING COFACTOR FOR THE E3 UBIQUITIN LIGASE TRAF2

  2010cited by this paper
• A Novel Sphingosine Kinase Inhibitor Induces Autophagy in Tumor Cells

  2010cited by this paper
• Sphingosine Kinase 1 Induces Tolerance to Human Epidermal Growth Factor Receptor 2 and Prevents Formation of a Migratory Phenotype in Response to Sphingosine 1-Phosphate in Estrogen Receptor-Positive Breast Cancer Cells

  2010cited by this paper
• Pharmacology and Antitumor Activity of ABC294640, a Selective Inhibitor of Sphingosine Kinase-2

  2010cited by this paper
• The Sphingosine Kinase 1 Inhibitor 2-(p-Hydroxyanilino)-4-(p-chlorophenyl)thiazole Induces Proteasomal Degradation of Sphingosine Kinase 1 in Mammalian Cells*

  2010influential reference
• Antiestrogenic effects of the novel sphingosine kinase-2 inhibitor ABC294640.

  2010cited by this paper
• Sphingosine 1-phosphate and cancer

  2010cited by this paper
• A Novel Mode of Action of the Putative Sphingosine Kinase Inhibitor 2-(p-hydroxyanilino)-4-(p-chlorophenyl) Thiazole (SKI II): Induction of Lysosomal Sphingosine Kinase 1 Degradation

  2010cited by this paper
• (S)-FTY720-vinylphosphonate, an analogue of the immunosuppressive agent FTY720, is a pan-antagonist of sphingosine 1-phosphate GPCR signaling and inhibits autotaxin activity.

  2010cited by this paper
• Regulation of Histone Acetylation in the Nucleus by Sphingosine-1-Phosphate

  2009cited by this paper
• Transforming growth factor-beta2 upregulates sphingosine kinase-1 activity, which in turn attenuates the fibrotic response to TGF-beta2 by impeding CTGF expression.

  2009cited by this paper
• Targeting sphingosine kinase 1 inhibits Akt signaling, induces apoptosis, and suppresses growth of human glioblastoma cells and xenografts.

  2009cited by this paper
• A selective sphingosine kinase 1 inhibitor integrates multiple molecular therapeutic targets in human leukemia.

  2008cited by this paper
• Filamin A Links Sphingosine Kinase 1 and Sphingosine-1-Phosphate Receptor 1 at Lamellipodia To Orchestrate Cell Migration

  2008cited by this paper
• Sphingosine kinase 1 regulates differentiation of human and mouse lung fibroblasts mediated by TGF-beta1.

  2007cited by this paper
• Sphingosine Kinase 1 Regulates Differentiation of Human and Mouse Lung Fibroblasts Mediated by TGF-β1

  2007cited by this paper
• Progesterone-induced sphingosine kinase-1 expression in the rat uterus during pregnancy and signaling consequences.

  2007cited by this paper
• Antitumor Activity of Sphingosine Kinase Inhibitors

  2006cited by this paper
• Interleukin 6, a Nuclear Factor-κB Target, Predicts Resistance to Docetaxel in Hormone-Independent Prostate Cancer and Nuclear Factor-κB Inhibition by PS-1145 Enhances Docetaxel Antitumor Activity

  2006cited by this paper
• Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages.

  2006cited by this paper
• Discovery and evaluation of inhibitors of human sphingosine kinase.

  2003cited by this paper
• A novel immunosuppressive agent FTY720 induced Akt dephosphorylation in leukemia cells

  2003cited by this paper
• Phosphorylation of the Immunomodulatory Drug FTY720 by Sphingosine Kinases*

  2003cited by this paper
• The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors*

  2002influential reference

• SphK Inhibitor ZFP-B34 Suppresses the Growth of TNBC Cells.

  2025cites this paper
• Potential of SPHK1 as a prognostic marker and therapeutic target in colorectal cancer: insights from bioinformatics and experimental analysis.

  2025cites this paper
• Multiple sphingolipid-metabolizing enzymes modulate influenza virus replication.

  2024cites this paper
• The emerging roles of sphingosine 1-phosphate and SphK1 in cancer resistance: a promising therapeutic target

  2024cites this paper
• The Drug Transporter P-Glycoprotein and Its Impact on Ceramide Metabolism—An Unconventional Ally in Cancer Treatment

  2024cites this paper
• Targeting SphK1/2 by SKI-178 inhibits prostate cancer cell growth

  2023cites this paper
• Prognosis-related metabolic genes in the development of colorectal cancer progress and perspective.

  2023cites this paper
• Revealing 2-dimethylhydrazino-2-alkyl alkynyl sphingosine derivatives as sphingosine kinase 2 inhibitors: Some hints on the structural basis for selective inhibition.

  2022cites this paper
• In Silico Identification of Protein Targets for Drug-like Compounds from Epicarp Extract of Cola rostrata K. Shum

  2022cites this paper
• Differential Expression of the Sphingolipid Pathway Is Associated with Sensitivity to the PP2A Activator FTY720 in Colorectal Cancer Cell Lines

  2021cites this paper
• Druggable Sphingolipid Pathways: Experimental Models and Clinical Opportunities

  2020cites this paper
• Sphingosine Kinase 1 Regulates the Survival of Breast Cancer Stem Cells and Non-stem Breast Cancer Cells by Suppression of STAT1

  2020cites this paper
• Targeting the Sphingolipid System as a Therapeutic Direction for Glioblastoma

  2020cites this paper
• Personalized and translational approach for malignant brain tumors in the era of precision medicine: the strategic contribution of an experienced neurosurgery laboratory in a modern neurosurgery and neuro-oncology department.

  2020cites this paper
• Leucine-rich Repeats and Immunoglobulin 1 (LRIG1) Ameliorates Liver Fibrosis and Hepatic Stellate Cell Activation via Inhibiting Sphingosine Kinase 1 (SphK1)/Sphingosine-1-Phosphate (S1P) Pathway.

  2020cites this paper
• Verification of the Necessity of the Tolyl Group of PF-543 for Sphingosine Kinase 1 Inhibitory Activity

  2020cites this paper
• Emerging roles of lysophospholipids in health and disease.

  2020cites this paper
• Entosis and apical cell extrusion constitute a tumor-suppressive mechanism downstream of Matriptase

  2019cites this paper
• Sphingosine kinase 2 inhibitor ABC294640 displays anti-epithelial ovarian cancer activities in vitro and in vivo

  2019cites this paper
• Expression of Sphingosine Kinase-1 Is Associated with Invasiveness and Poor Prognosis of Oral Squamous Cell Carcinoma.

  2018cites this paper
• Fluorinated triazole-containing sphingosine analogues. Syntheses and in vitro evaluation as SPHK inhibitors.

  2018cites this paper
• Targeting Sphingosine Kinases for the Treatment of Cancer: CHAPTER ELEVEN

  2018cites this paper
• Targeting sphingosine kinase 2 by ABC294640 inhibits human skin squamous cell carcinoma cell growth.

  2018cites this paper
• Pharmacokinetics of Jaspine B and Enhancement of Intestinal Absorption of Jaspine B in the Presence of Bile Acid in Rats

  2017cites this paper
• NMR metabolomics highlights sphingosine kinase‐1 as a new molecular switch in the orchestration of aberrant metabolic phenotype in cancer cells

  2017cites this paper
• Sphingosine 1-phosphate signaling through its receptor S1P5 promotes chromosome segregation and mitotic progression

  2017cites this paper
• The sphingosine kinase 2 inhibitor ABC294640 inhibits cervical carcinoma cell growth

  2017cites this paper
• On the role of bioactive sphingolipids and their metabolizing enzymes in cancer

  2017cites this paper
• Therapeutic Strategies and Pharmacological Tools Influencing S1P Signaling and Metabolism

  2017cites this paper
• Interactions entre CCR5 et trois récepteurs couplés aux protéines G : EBI2, A2A et S1P1 : effets sur l'infection par le VIH-1, mécanismes d'action et perspectives thérapeutiques

  2017cites this paper
• Thinking inside and outside the blood vessel: S1P-mediated control of vascular tone and the impact of CMV infection

  2016cites this paper
• Inhibitors of sphingosine-1-phosphate metabolism (sphingosine kinases and sphingosine-1-phosphate lyase).

  2016cites this paper
• Major apoptotic mechanisms and genes involved in apoptosis

  2016cites this paper
• Essential role for SphK1/S1P signaling to regulate hypoxia-inducible factor 2α expression and activity in cancer

  2016cites this paper
• Sphingosine Kinase Inhibitors as Maintenance Therapy of Glioblastoma After Ceramide-Induced Response.

  2016cites this paper
• Differential Cytotoxic Effects of Jaspine B in Various Cancer Cells

  2016cites this paper
• Scintillation Proximity Assay to Detect the Changes in Cellular Dihydrosphingosine 1-Phosphate Levels

  2016cites this paper
• An insight into the role of arachidonic acid derived lipid mediators in virus associated pathogenesis and malignancies.

  2016cites this paper
• Sphingosine 1-phosphate signaling impacts lymphocyte migration, inflammation and infection.

  2016cites this paper
• Sphingosine 1-Phosphate Activation of EGFR As a Novel Target for Meningitic Escherichia coli Penetration of the Blood-Brain Barrier

  2016cites this paper
• Reduction in sphingosine kinase 1 influences the susceptibility to dengue virus infection by altering antiviral responses.

  2016cites this paper
• Targeting sphingosine kinase 2 (SphK2) by ABC294640 inhibits colorectal cancer cell growth in vitro and in vivo

  2015cites this paper
• New extracellular factors in glioblastoma multiforme development: neurotensin, growth differentiation factor-15, sphingosine-1-phosphate and cytomegalovirus infection

  2015cites this paper
• The impact of sphingosine kinase inhibitor-loaded nanoparticles on bioelectrical and biomechanical properties of cancer cells

  2015cites this paper
• Sphingosine kinase 1 is a reliable prognostic factor and a novel therapeutic target for uterine cervical cancer

  2015cites this paper
• FTY720 (Fingolimod) sensitizes hepatocellular carcinoma cells to sorafenib-mediated cytotoxicity

  2015cites this paper
• Dengue Virus-Induced Inflammation of the Endothelium and the Potential Roles of Sphingosine Kinase-1 and MicroRNAs

  2015cites this paper
• Src inhibitors act through different mechanisms in Non-Small Cell Lung Cancer models depending on EGFR and RAS mutational status

  2015cites this paper
• TGFβ-Mediated induction of SphK1 as a potential determinant in human MDA-MB-231 breast cancer cell bone metastasis.

  2015influential citation
• Hair Cell Loss Induced by Sphingosine and a Sphingosine Kinase Inhibitor in the Rat Cochlea

  2015cites this paper
• Sphingosine kinase 1 as a potential therapeutic target in epithelial ovarian cancer

  2015cites this paper
• Involvement of vacuolar H+‐ATPase in killing of human melanoma cells by the sphingosine kinase analogue FTY720

  2015cites this paper
• Expression levels of bioactive sphingolipid genes in newly diagnosed and drug-resistant chronic myeloid leukemia patients and their impact on the clinical progress

  2015cites this paper
• Chemical Probes of Sphingolipid Metabolizing Enzymes

  2015cites this paper
• The Role of Sphingosine Kinase 1 in HER2/Neu-Induced Breast Tumorigenesis

  2015influential citation
• Nanoparticle-Based Drug Delivery and the Impacts on Cancer Cell Biophysical Markers

  2015cites this paper
• Can we cure CML without transplantation

  2014cites this paper
• A sphingosine kinase inhibitor combined with temozolomide induces glioblastoma cell death through accumulation of dihydrosphingosine and dihydroceramide, endoplasmic reticulum stress and autophagy

  2014cites this paper
• Impact of acetylation on tumor metabolism

  2014cites this paper
• Inhibition of dihydroceramide desaturase activity by the sphingosine kinase inhibitor SKI II[S]

  2014cites this paper
• LRIG1 modulates aggressiveness of head and neck cancers by regulating EGFR-MAPK-SPHK1 signaling and extracellular matrix remodeling

  2014cites this paper
• Sphingosine kinase 1 enables communication between melanoma cells and fibroblasts that provides a new link to metastasis

  2014cites this paper
• Synthesis of aromatic sphingosine analogues by diastereoselective amination of enantioenriched trans-γ,δ-unsaturated β-hydroxyesters.

  2014cites this paper
• Sphingosine analog fingolimod (FTY720) increases radiation sensitivity of human breast cancer cells in vitro

  2014cites this paper
• Synthesis of (S)-FTY720 vinylphosphonate analogues and evaluation of their potential as sphingosine kinase 1 inhibitors and activators.

  2013cites this paper
• Tandem oxidative radical fragmentation–rearrangement of 2-amino-1,3-benzylidene acetals: a short entry to densely functionalised fully differentiated oxazolidinones

  2013cites this paper
• Regulation of cell survival by sphingosine-1-phosphate receptor S1P1 via reciprocal ERK-dependent suppression of Bim and PI-3-kinase/protein kinase C-mediated upregulation of Mcl-1

  2013influential citation
• Emerging roles of lipids in BCL-2 family-regulated apoptosis.

  2013cites this paper
• Synthesis Of Natural Product-Based Sphingosine Derivatives

  2013cites this paper
• Sphingosine kinase 1 in viral infections

  2013cites this paper
• Targeting survival pathways in chronic myeloid leukaemia stem cells

  2013cites this paper
• Biological Characterization of 3-(2-amino-ethyl)-5-[3-(4-butoxyl-phenyl)-propylidene]-thiazolidine-2,4-dione (K145) as a Selective Sphingosine Kinase-2 Inhibitor and Anticancer Agent

  2013cites this paper
• Natural products as platforms for the design of sphingolipid-related anticancer agents.

  2013cites this paper
• The Role of an Oncoprotein CIP2A in Breast Cancer

  2013cites this paper
• D-Glucosamine-derived synthons for assembly of L-threo-sphingoid bases. Total synthesis of rhizochalinin C.

  2013cites this paper
• A biologically relevant ceramide fluorescent probe to assess the binding of potential ligands to the CERT transfer protein

  2013cites this paper
• Novel sphingosine-containing analogues selectively inhibit sphingosine kinase (SK) isozymes, induce SK1 proteasomal degradation and reduce DNA synthesis in human pulmonary arterial smooth muscle cells.

  2013cites this paper
• Sphingosine kinase 1 in cancer.

  2013cites this paper
• Bringing balance by force: live cell extrusion controls epithelial cell numbers.

  2013cites this paper
• Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond

  2013cites this paper
• The sphingosine kinase inhibitor 2‐(p‐hyroxyanilino)‐4‐(p‐chlorophenyl)thiazole reduces androgen receptor expression via an oxidative stress‐dependent mechanism

  2013cites this paper
• Structure and catalytic function of sphingosine kinases: analysis by site-directed mutagenesis and enzyme kinetics.

  2013cites this paper
• The Impact of Sphingosine Kinase-1 in Head and Neck Cancer

  2013cites this paper
• Identification of novel functional and spatial associations between sphingosine kinase 1, sphingosine 1‐phosphate receptors and other signaling proteins that affect prognostic outcome in estrogen receptor‐positive breast cancer

  2013cites this paper
• Design, synthesis, and biological evaluation of selective sphingosine kinase inhibitors

  2012cites this paper
• Sphingosine kinase: a key to solving the

  2012cites this paper
• Anti-cancer drug development: computational strategies to identify and target proteins involved in cancer metabolism.

  2012cites this paper
• Effect of alkyl chain length on sphingosine kinase 2 selectivity.

  2012cites this paper
• Sphingosine Kinase 1 Overexpression Contributes to Cetuximab Resistance in Human Colorectal Cancer Models

  2012cites this paper
• Investigations Into The Chemoselective Modification Of THAM Directed Towards Biological Applications

  2012cites this paper
• Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A-RIPK1-dependent necroptosis

  2012cites this paper
• Sphingosine kinase: a key to solving the ‘French Paradox’?

  2012influential citation
• Inhibition kinetics and regulation of sphingosine kinase 1 expression in prostate cancer cells: functional differences between sphingosine kinase 1a and 1b.

  2012cites this paper
• Novel agents targeting bioactive sphingolipids for the treatment of cancer.

  2012cites this paper
• Analysis of sphingolipid and prostaglandin synthesis during zymosan-induced inflammation.

  2012cites this paper
• FTY720, sphingosine 1-phosphate receptor modulator, selectively radioprotects hippocampal neural stem cells.

  2012cites this paper
• Metabolic Profiling Reveals Sphingosine-1-Phosphate Kinase 2 and Lyase as Key Targets of (Phyto-) Estrogen Action in the Breast Cancer Cell Line MCF-7 and Not in MCF-12A

  2012cites this paper